Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells

Aitchison, 2000, Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice, J. Psychopharmacol., 14, 353, 10.1177/026988110001400403 Arranz, 1995, Cytochrome P4502D6 genotype does not determine response to clozapine, Br. J. Clin. Pharmacol., 39, 417, 10.1111/j.1365-2125.1995.tb04471.x Aymard, 1997, Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels, Therapies, 52, 227 Beyenburg, 2001, Messenger RNA of steroid 21-hydroxylase (CYP21) is expressed in the human hippocampus, Neurosci. Lett., 308, 111, 10.1016/S0304-3940(01)01991-7 Combs, 1997, N-Desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia, Pharmacotherapy, 17, 1300, 10.1002/j.1875-9114.1997.tb03096.x Dailly, 2002, Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance, Prog. Neuro-psychopharmacol. Biol. Psychiatry, 26, 699, 10.1016/S0278-5846(01)00320-7 Dean, 1996, Serotonin2 receptors and the serotonin transporter in the schizophrenic brain, Behav. Brain Res., 73, 169, 10.1016/0166-4328(96)00091-5 Dettling, 2000, Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients, Psychopharmacology (Berl.), 152, 80, 10.1007/s002130000503 Eiermann, 1997, The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine, Br. J. Clin. Pharmacol., 44, 439, 10.1046/j.1365-2125.1997.t01-1-00605.x Fang, 1998, Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine, Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 592, 10.1007/PL00005298 Grace, 2000, Gating of information flow within the limbic system and the pathophysiology of schizophrenia, Brain Res. Rev., 31, 330, 10.1016/S0165-0173(99)00049-1 Guitton, 1998, Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia, J. Clin. Psychopharmacol., 18, 470, 10.1097/00004714-199812000-00010 Hagg, 1999, Absence of interaction between erythromycin and a single dose of clozapine, Eur. J. Clin. Pharmacol., 55, 221, 10.1007/s002280050621 Henning, 2002, Uptake of clozapine into HL-60 promyelocytic leukaemia cells, Pharmacopsychiatry, 35, 90, 10.1055/s-2002-31516 Henning, 2002, Transport of clozapine and its major metabolites into human cells of glial and neuronal origin, Eur. Arch. Psychiatry Clin. Neurosci., 252, P210 Huang, 2000, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the arylhydrocarbon receptor nuclear translocator in rat brain and pituitary, Toxicol. Appl. Pharmacol., 169, 159, 10.1006/taap.2000.9064 Joyce, 1993, Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics, Neuropsychopharmacology, 8, 315, 10.1038/npp.1993.32 Kuperberg, 2000, Schizophrenia and cognitive function, Curr. Opin. Neurobiol., 10, 205, 10.1016/S0959-4388(00)00068-4 Linnet, 1997, Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes, Drug Metab. Dispos., 25, 1379 Martin, 2001, cyp7b1 catalyses the 7alpha-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate, Biochem. J., 355, 509, 10.1042/0264-6021:3550509 Morimoto, 1990, Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line, Neuron, 5, 875, 10.1016/0896-6273(90)90347-I Morse, 1998, Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain, Toxicol. Appl. Pharmacol., 152, 232, 10.1006/taap.1998.8477 Nadel, 2000, Multiple trace theory of human memory: computational, neuroimaging, and neuropsychological results, Hippocampus, 10, 352, 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.0.CO;2-D Naylor, 1996, Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine, J. Neural Transm. Gen. Sec., 103, 749, 10.1007/BF01271234 Norris, 1996, Regional distribution of cytochrome P450 2D1 in the rat central nervous system, J. Comp. Neurol., 366, 244, 10.1002/(SICI)1096-9861(19960304)366:2<244::AID-CNE5>3.0.CO;2-5 Odou, 1996, Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites, J. Clin. Pharm. Ther., 21, 337, 10.1111/j.1365-2710.1996.tb00028.x Ozdemir, 2001, Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C→A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine, J. Clin. Psychopharmacol., 21, 603, 10.1097/00004714-200112000-00011 Ozdemir, 2001, CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentration in patients with schizophrenia, J. Clin. Psychopharmacol., 21, 398, 10.1097/00004714-200108000-00007 Prior, 1999, Drug metabolism and atypical antipsychotics, Eur. Neuropsychopharmacol., 9, 301, 10.1016/S0924-977X(98)00040-6 Raaska, 1998, Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole, Eur. J. Clin. Pharmacol., 54, 167, 10.1007/s002280050440 Rane, 1996, Differential effects of neuroleptic agents on hepatic cytochrome P-450 isozymes in the male rat, Biochim. Biophys. Acta, 1291, 60, 10.1016/0304-4165(96)00046-3 Remschmidt, 1994, An open trial of clozapine in thirty-six adolescents with schizophrenia, J. Child Adolesc. Psychopharmacol., 4, 31, 10.1089/cap.1994.4.31 Riedl, 2000, Expression and distribution of CYP2C enzymes in rat basal ganglia, Synapse, 38, 392, 10.1002/1098-2396(20001215)38:4<392::AID-SYN4>3.0.CO;2-Z Scarr, 2001, A proposed pathological model in the hippocampus of subjects with schizophrenia, Clin. Exp. Pharmacol. Physiol., 28, 70, 10.1046/j.1440-1681.2001.03400.x Schoedel, 2001, Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain, Biochem. Pharmacol., 62, 1025, 10.1016/S0006-2952(01)00744-4 Schulz, 1995, Determination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high performance liquid chromatography. Data from a prospective clinical trial, Pharmacopsychiatry, 28, 20, 10.1055/s-2007-979583 Schulz, 1997, Blood biogenic amines during clozapine treatment of early-onset schizophrenia, J. Neural Transm., 104, 1077, 10.1007/BF01273320 Seeman, 1993 Siegle, 2001, Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain, Pharmacogenetics, 11, 237, 10.1097/00008571-200104000-00007 Stoffel-Wagner, 1999, Expression of CYP19 (aromatase) mRNA in different areas of the human brain, J. Steroid Biochem. Mol. Biol., 70, 237, 10.1016/S0960-0760(99)00114-4 Taylor, 1999, The effect of nefazodone on clozapine plasma concentrations, Int. Clin. Psychopharmacol., 14, 185, 10.1097/00004850-199905002-00007 Tindberg, 1996, Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system, J. Neurochem., 67, 2066, 10.1046/j.1471-4159.1996.67052066.x Upadhya, 2000, Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization, Arch. Biochem. Biophys., 373, 23, 10.1006/abbi.1999.1477 Vedder, 1999, Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone, J. Psychiatr. Res., 33, 303, 10.1016/S0022-3956(99)00006-0 Watzka, 1999, Sex- and age-specific differences in human brain CYP11A1 mRNA expression, J. Neuroendocrinol., 11, 901, 10.1046/j.1365-2826.1999.00407.x Young, 1998, Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite, Neuropsychopharmacology, 19, 99, 10.1016/S0893-133X(97)00203-0